Literature DB >> 10648827

The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation.

E Bender1, B Kadenbach.   

Abstract

In previous studies the allosteric inhibition of cytochrome c oxidase at high intramitochondrial ATP/ADP-ratios via binding of the nucleotides to the matrix domain of subunit IV was demonstrated. Here we show that the allosteric ATP-inhibition of the isolated bovine heart enzyme is switched on by cAMP-dependent phosphorylation with protein kinase A of subunits II (and/or III) and Vb, and switched off by subsequent incubation with protein phosphatase 1. It is suggested that after cAMP-dependent phosphorylation of cytochrome c oxidase mitochondrial respiration is controlled by the ATP/ADP-ratio keeping the proton motive force Deltap low, and the efficiency of energy transduction high. After Ca(2+)-induced dephosphorylation this control is lost, accompanied by increase of Deltap, slip of proton pumping (decreased H(+)/e(-) stoichiometry), and increase of the rate of respiration and ATP-synthesis at a decreased efficiency of energy transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648827     DOI: 10.1016/s0014-5793(99)01773-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  69 in total

1.  Regulation of oxidative phosphorylation complex activity: effects of tissue-specific metabolic stress within an allometric series and acute changes in workload.

Authors:  Darci Phillips; Raul Covian; Angel M Aponte; Brian Glancy; Joni F Taylor; David Chess; Robert S Balaban
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

Review 2.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

Review 3.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

Review 5.  Control of energy metabolism by iodothyronines.

Authors:  A Lanni; M Moreno; A Lombardi; P de Lange; F Goglia
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

6.  Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury.

Authors:  Subbuswamy K Prabu; Hindupur K Anandatheerthavarada; Haider Raza; Satish Srinivasan; Joseph F Spear; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

7.  Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase.

Authors:  Icksoo Lee; Elisabeth Bender; Bernhard Kadenbach
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Cytochrome c oxidase dysfunction in oxidative stress.

Authors:  Satish Srinivasan; Narayan G Avadhani
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

Review 9.  Redox signaling and protein phosphorylation in mitochondria: progress and prospects.

Authors:  D Brian Foster; Jennifer E Van Eyk; Eduardo Marbán; Brian O'Rourke
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

10.  Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects.

Authors:  Rebeca Acin-Perez; Eric Salazar; Sonja Brosel; Hua Yang; Eric A Schon; Giovanni Manfredi
Journal:  EMBO Mol Med       Date:  2009-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.